This Article Full Text Full Text (PDF) All Versions of this Article: 22/5/e1    most recent 01.ATV.0000016248.51577.1Fv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, J. Articles by Wang, X. L. Search for Related Content PubMed PubMed Citation Articles by Wang, J. Articles by Wang, X. L. Related Collections Risk Factors Gene regulation Endothelium/vascular type/nitric oxide

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:e1.)
© 2002 American Heart Association, Inc.

Vascular Biology

Haplotype-Specific Effects on Endothelial NO Synthase Promoter Efficiency

Modifiable by Cigarette Smoking

Jian Wang; Donald Dudley; Xing Li Wang

From the Department of Genetics (J.W., X.L.W.), Southwest Foundation for Biomedical Research, and Department of Obstetrics and Gynecology (D.D.), University of Texas Health Science Center–San Antonio.

Correspondence to Dr. X.L. Wang, Department of Genetics, Southwest Foundation for Biomedical Research, PO Box 760549, San Antonio, TX 78245-0549. E-mail xwang{at}darwin.sfbr.org

The T–786C promoter and 27-bp repeat intron 4 polymorphisms in the endothelial NO synthase (eNOS) gene have been inconsistently associated with various eNOS-related phenotypic changes. We explored molecular mechanisms underlying the inconsistency. We constructed pGL3 luciferase reporter vectors by inserting an eNOS promoter fragment containing either T or C nucleotide at -786 bp at the 5' end of the luciferase coding region and eNOS intron 4 containing either 5x or 4x27-bp repeats at the 3' end of the luciferase gene. The transcription efficiency in the T promoter was lower than in the C promoter (15.7±1.0% vs 83.3±5.8%, P<0.01 when 5x27-bp was an enhancer and 37.6±4.7% vs 58.9±7.5%, P<0.01 when 4x27bp was an enhancer). Although cigarette smoking extracts treatment increased the transcription efficiency significantly in the T promoter (1.7-fold, P<0.01), it reduced the C promoter efficiency (by 10% to 15%). A mobility shift assay revealed positive binding of the 27-bp repeat fragment with endothelial cell nuclear protein extracts. Our study demonstrates a cis-acting role of the 27-bp repeats in eNOS promoter function and a haplotype-specific expression pattern determined by DNA variants at -786 bp and intron 4 of the eNOS gene that is also modifiable by cigarette smoking.

Key Words: gene • gene regulation • smoking • haplotypes • endothelial NO synthase

This article has been cited by other articles:

				G. Dhangadamajhi, B. N. Mohapatra, S. K. Kar, and M. Ranjit Endothelial Nitric Oxide Synthase Gene Polymorphisms and Plasmodium falciparum Infection in Indian Adults Infect. Immun., July 1, 2009; 77(7): 2943 - 2947. [Abstract] [Full Text] [PDF]

				M.-X. Zhang, C. Zhang, Y. H. Shen, J. Wang, X. N. Li, Y. Zhang, J. Coselli, and X. L. Wang Biogenesis of Short Intronic Repeat 27-Nucleotide Small RNA from Endothelial Nitric-oxide Synthase Gene J. Biol. Chem., May 23, 2008; 283(21): 14685 - 14693. [Abstract] [Full Text] [PDF]

				F. Sen, M. Demirturk, N. Abaci, E. Golcuk, H. Oflaz, A. Elitok, F. Kutluturk, H. Issever, N. E. Unaltuna, and N. C. Ozbey Endothelial nitric oxide synthase intron 4a/b polymorphism and early atherosclerotic changes in hypopituitary GH-deficient adult patients Eur. J. Endocrinol., May 1, 2008; 158(5): 615 - 622. [Abstract] [Full Text] [PDF]

				H. S. Markus Genes, endothelial function and cerebral small vessel disease in man Exp Physiol, January 1, 2008; 93(1): 121 - 127. [Abstract] [Full Text] [PDF]

				E. T. Cirulli and D. B. Goldstein In vitro assays fail to predict in vivo effects of regulatory polymorphisms Hum. Mol. Genet., August 15, 2007; 16(16): 1931 - 1939. [Abstract] [Full Text] [PDF]

				E. Zintzaras, G. Kitsios, and I. Stefanidis Endothelial NO Synthase Gene Polymorphisms and Hypertension: A Meta-Analysis Hypertension, October 1, 2006; 48(4): 700 - 710. [Abstract] [Full Text] [PDF]

				H. Ou, Y. H. Shen, B. Utama, J. Wang, X. Wang, J. Coselli, and X. L. Wang Effect of Nuclear Actin on Endothelial Nitric Oxide Synthase Expression Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2509 - 2514. [Abstract] [Full Text] [PDF]

				M.-X. Zhang, H. Ou, Y. H. Shen, J. Wang, J. Wang, J. Coselli, and X. Li Wang Regulation of endothelial nitric oxide synthase by small RNA PNAS, November 22, 2005; 102(47): 16967 - 16972. [Abstract] [Full Text] [PDF]

				T. D. Howard, W. H. Giles, J. Xu, M. A. Wozniak, A. M. Malarcher, L. A. Lange, R. F. Macko, M. J. Basehore, D. A. Meyers, J. W. Cole, et al. Promoter Polymorphisms in the Nitric Oxide Synthase 3 Gene Are Associated With Ischemic Stroke Susceptibility in Young Black Women Stroke, September 1, 2005; 36(9): 1848 - 1851. [Abstract] [Full Text] [PDF]

				Y. Gan, Y. H. Shen, J. Wang, X. Wang, B. Utama, J. Wang, and X. L. Wang Role of Histone Deacetylation in Cell-specific Expression of Endothelial Nitric-oxide Synthase J. Biol. Chem., April 22, 2005; 280(16): 16467 - 16475. [Abstract] [Full Text] [PDF]

				T. Awata, T. Neda, H. Iizuka, S. Kurihara, T. Ohkubo, N. Takata, M. Osaki, M. Watanabe, Y. Nakashima, T. Sawa, et al. Endothelial Nitric Oxide Synthase Gene Is Associated With Diabetic Macular Edema in Type 2 Diabetes Diabetes Care, September 1, 2004; 27(9): 2184 - 2190. [Abstract] [Full Text] [PDF]

				A. Hassan, K. Gormley, M. O'Sullivan, J. Knight, P. Sham, P. Vallance, J. Bamford, and H. Markus Endothelial Nitric Oxide Gene Haplotypes and Risk of Cerebral Small-Vessel Disease Stroke, March 1, 2004; 35(3): 654 - 659. [Abstract] [Full Text] [PDF]